Skip to main content

Advertisement

Log in

Photobiomodulation: a promising innovative approach for preventing oral mucositis in patients undergoing hematopoietic stem cell transplantation

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

This single-center retrospective study aims to assess the feasibility, safety, and tolerability of CareMin650, a new photobiomodulation device, for both preventing oral mucositis (OM) and reducing its severity in the setting of hematopoietic stem cell transplantation (HCT).

Methods

Patients who underwent autologous HCT for hematological malignancies between November 2020 and October 2021 could be included. Prophylactic photobiomodulation (PBM) was used daily from day 1 of conditioning until the day of neutrophil recovery at a dose of 3 J/cm2. Curative PBM was started at a dose of 6 J/cm2 when at least one grade 1 OM had occurred. For each OM case, time of onset, National Cancer Institute-Common Terminology Criteria for Adverse Events (NCI-CTCAE) v5.0 grade for OM, analgesic dose, and time to resolution were reported.

Results

Twenty-five consecutive patients were included. The median age was 58 years (range, 39–74) and 14 (56%) were male. Twenty-one patients (84%) received a high-dose melphalan conditioning regimen for multiple myeloma, and 4 (16%) patients received BEAM conditioning for aggressive lymphoma. A total of 178 CareMin650 sessions were performed, with a median of 7 days of application (range, 4–12), with no device-related adverse events (AEs). According to the NCI-CTCAE v5.0 scale, 76% (19 of 25) of patients presented grade 0 or 1 mucositis (no ulcers), five patients (20%) developed small ulcers (grade 2), and only one patient developed grade 4 mucositis. Satisfaction rates were high among patients and users.

Conclusion

Photobiomodulation provides excellent safety and tolerance, as well as promising efficacy, both as a preventive and curative strategy, in patients undergoing autologous HCT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Batlle M, Morgades M, Vives S, Ferra C, Oriol A, Sancho JM, Xicoy B, Moreno M, Magallon L, Ribera JM (2014) Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma. Eur J Haematol 93:487–491

    Article  CAS  Google Scholar 

  2. Baysal E, Sari D, Vural F, Cagirgan S, Saydam G, Tobu M, Sahin F, Soyer N, Gediz F, Acarlar C, Timur E, Gungor A (2021) The effect of cryotherapy on the prevention of oral mucositis and on the oral pH value in multiple myeloma patients undergoing autologous stem cell transplantation. Semin Oncol Nurs 37:151146

    Article  Google Scholar 

  3. Bensadoun RJ, Bollet MA, Liem X, Cao K, Magne N (2022) New photobiomodulation device for prevention and cure of radiotherapy-induced oral mucositis and dermatitis: results of the prospective Safe PBM study. Support Care Cancer 30:1569–1577

    Article  Google Scholar 

  4. Bensadoun RJ, Nair RG (2012) Low-level laser therapy in the prevention and treatment of cancer therapy-induced mucositis: 2012 state of the art based on literature review and meta-analysis. Curr Opin Oncol 24:363–370

    Article  CAS  Google Scholar 

  5. Bjordal JM, Bensadoun RJ, Tuner J, Frigo L, Gjerde K, Lopes-Martins RA (2011) A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Support Care Cancer 19:1069–1077

    Article  Google Scholar 

  6. Carulli G, Rocco M, Panichi A, Chios CF, Ciurli E, Mannucci C, Sordi E, Caracciolo F, Papineschi F, Benedetti E, Petrini M (2013) Treatment of oral mucositis in hematologic patients undergoing autologous or allogeneic transplantation of peripheral blood stem cells: a prospective, randomized study with a mouthwash containing Camelia sinensis leaf extract. Hematol Rep 5:21–25

    Article  Google Scholar 

  7. Chen J, Seabrook J, Fulford A, Rajakumar I (2017) Icing oral mucositis: oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant. J Oncol Pharm Pract 23:116–120

    Article  Google Scholar 

  8. Clarkson JE, Worthington HV, Furness S et al (2010) Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev (8):CD001973

  9. Correa MEP, Cheng KKF, Chiang K, Kandwal A, Loprinzi CL, Mori T, Potting C, Rouleau T, Toro JJ, Ranna V, Vaddi A, Peterson DE, Bossi P, Lalla RV, Elad S (2020) Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 28:2449–2456

    Article  Google Scholar 

  10. Courtois E, Bouleftour W, Guy JB, Louati S, Bensadoun RJ, Rodriguez-Lafrasse C, Magne N (2021) Mechanisms of photobiomodulation (PBM) focused on oral mucositis prevention and treatment: a scoping review. BMC Oral Health 21:220

    Article  Google Scholar 

  11. Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V, Bossi P (2020) Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in C, International Society of Oral O MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 126:4423–4431

    Article  Google Scholar 

  12. Huang YY, Sharma SK, Carroll J, Hamblin MR (2011) Biphasic dose response in low level light therapy - an update. Dose Response 9:602–618

    Article  CAS  Google Scholar 

  13. Lalla RV, Sonis ST, Peterson DE (2008) Management of oral mucositis in patients who have cancer. Dent Clin North Am 52:61–77 (viii)

    Article  Google Scholar 

  14. Lilleby K, Garcia P, Gooley T, McDonnnell P, Taber R, Holmberg L, Maloney DG, Press OW, Bensinger W (2006) A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 37:1031–1035

    Article  CAS  Google Scholar 

  15. Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL, Hodgson B, Lopes NN, Schubert MM, Bowen J, Elad S (2013) Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral O Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer 21:333–341

    Article  Google Scholar 

  16. Oberoi S, Zamperlini-Netto G, Beyene J, Treister NS, Sung L (2014) Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS ONE 9:e107418

    Article  Google Scholar 

  17. Salvador P, Azusano C, Wang L, Howell D (2012) A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients. J Pain Symptom Manage 44:64–73

    Article  Google Scholar 

  18. Salvador PT (2005) Factors influencing the incidence and severity of oral mucositis in patients undergoing autologous stem cell transplantation. Can Oncol Nurs J 15:29–34

    Article  Google Scholar 

  19. Wang L, Gu Z, Zhai R, Zhao S, Luo L, Li D, Zhao X, Wei H, Pang Z, Wang L, Liu D, Wang Q, Gao C (2015) Efficacy of oral cryotherapy on oral mucositis prevention in patients with hematological malignancies undergoing hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials. PLoS ONE 10:e0128763

    Article  Google Scholar 

  20. Zadik Y, Arany PR, Fregnani ER, Bossi P, Antunes HS, Bensadoun RJ, Gueiros LA, Majorana A, Nair RG, Ranna V, Tissing WJE, Vaddi A, Lubart R, Migliorati CA, Lalla RV, Cheng KKF, Elad S (2019) Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral O Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines Support Care. Cancer 27:3969–3983

    Google Scholar 

Download references

Acknowledgements

The authors acknowledge NeoMedLight, 90 rue Frédéric Fays, 69100 Villeurbanne, France, and Cell Therapies Research & Services (CTRS), 63 rue de l’Est, 92100 Boulogne-Billancourt, France, for their generous and continuous support of this research work. The authors also thank the clinical teams who cared for the study patients and for their dedication to this study.

Author information

Authors and Affiliations

Authors

Contributions

NS and EB designed the study, NS collected the data, and all authors recruited patients. NS and EB prepared the manuscript for publication. All authors analyzed the data, reviewed the manuscript, and agreed to its submission for publication.

Corresponding author

Correspondence to Nicolas Stocker.

Ethics declarations

Ethics approval

All study procedures complied with the ethical standards and the guidelines of the 1964 Declaration of Helsinki. There were no invasive procedures planned for human beings during the study period.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stocker, N., Baltes, V., Bellaiche, S. et al. Photobiomodulation: a promising innovative approach for preventing oral mucositis in patients undergoing hematopoietic stem cell transplantation. Support Care Cancer 30, 8211–8216 (2022). https://doi.org/10.1007/s00520-022-07280-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-022-07280-3

Keywords

Navigation